Perakizumab, being investigated by Novan, offers a significant step in the management against several fibrotic conditions. Different from traditional therapies, this molecule specifically targets and transforming https://bookmark-template.com/story28769659/perakizumab-a-potential-hope-for-fibrosis-conditions